UPB Competitors & Alternatives
Compare Upstream Bio, Inc. with similar stocks in the same industry
Biotechnology
UPB
Main Stock$9.17
Tradestie Score
50
Market Cap
$1.00B
Revenue Growth
0.1%
Analyst Upside
+375.2%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$14.52
|
$540.97M | - | 56 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$11.21
|
$533.99M | - | 63 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.71
|
$529.35M | 7.3 | 57 | Compare |
|
OCGN
Ocugen, Inc. Common Stock
|
$1.65
|
$524.67M | - | 52 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.60
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$29.24
|
$505.12M | 1.6 | 64 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$7.18
|
$504.67M | - | 57 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$126.74
|
$492.21M | - | 57 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.86
|
$474.20M | 28.7 | 53 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$4.77
|
$468.01M | - | 53 | Compare |
More UPB Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry